NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I think it’s due to the originating status of this trial. To run trials in other indications for DCVax-l, the data, design, confidence and a host of other factors from this trial will be utilized to design shorter trials with logical endpoints, imo. You really can’t do that, unless the evidence is water tight enough that one can scientifically correlate certain endpoints to true efficacy. They took time now to save time later.